Insider Holders & Insider Ownership - BIOGEN INC. (BIIB)

List of insiders holdings for BIOGEN INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
MULLEN JAMES C
CEO & President
2010-06-10 19:54:591,297,633
75,000
1,372,633Form 4
HANNA NABIL
EVP Discovery Research
2004-04-05 19:24:30710,095
0
710,095Form 4
DENNER ALEXANDER J
Director
2022-06-17 16:29:0115,099
643,000
658,099Form 4
ROHN WILLIAM R
Chief Operating Officer
2004-11-19 14:09:11151,226
383,388
534,614Form 4
SHARP PHILIP A
Director
2009-06-05 11:07:10476,253
0
476,253Form 4
RASTETTER WILLIAM H
Executive Chairman
2005-07-01 11:34:2350,677
376,229
426,906Form 4
GREGOIRE SYLVIE L
EVP, Bus. Dev & Program Mgmt.
2003-11-14 20:42:33366,544
0
366,544Form 4
Vounatsos Michel
Chief Executive Officer
2022-02-23 16:21:11136,590
0
136,590Form 4
Arner Raymond G
Acting General Counsel
2005-06-27 20:08:33115,306
0
115,306Form 3
Cook Anne Marie
Acting General Counsel
2005-03-18 09:41:15112,882
0
112,882Form 3
HASLER HANS PETER
Chief Operating Officer
2009-02-26 17:31:20106,826
0
106,826Form 4
PICKETT CECIL B
President, R & D
2009-10-05 14:15:3188,732
0
88,732Form 4
BUCKNUM THOMAS J
EVP and General Counsel
2005-02-22 15:29:2075,500
0
75,500Form 4
Hasnain Faheem
EVP, Oncology/Rheumatology SBU
2008-07-10 14:08:0875,079
0
75,079Form 4
MATSUI CONNIE
EVP, Corp. Strategy and Comm.
2007-02-14 14:40:1433,837
40,766
74,603Form 4
Gilman Michael
EVP - Research
2005-02-22 15:15:0070,000
0
70,000Form 4
Kowolenko Michael
SVP, Pharm Ops & Technology
2007-07-27 10:57:5469,828
0
69,828Form 4
RODRIGUEZ EDWARD
VP and Controller
2003-09-03 18:22:5161,357
7,100
68,457Form 4
SCANGOS GEORGE A
Chief Executive Officer
2016-07-22 17:03:4954,779
10,756
65,535Form 4
BELZER ALAN
Director
2007-05-30 17:18:4141,500
11,500
53,000Form 4
ALEXANDER SUSAN H
EVP Chief Legal Officer
2024-11-07 16:23:1031,601
20,082
51,683Form 4
DUNN JOHN MICHAEL
EVP, New Ventures
2009-02-26 17:28:4740,822
0
40,822Form 4
Cox John
EVP Pharmaceutical Oper & Tech
2016-04-05 17:04:1739,045
0
39,045Form 4
PAPADOPOULOS STELIOS
Director
2022-06-17 17:13:3810,095
28,206
38,301Form 4
CAPELLO JEFFREY D
EVP & Chief Financial Officer
2020-02-14 18:27:3232,617
0
32,617Form 4
Guindo Chirfi
Head of Glob Prod Strat & Com
2022-02-23 16:15:5629,551
0
29,551Form 4
Hamm Robert A
Chief Operating Officer
2010-04-26 16:07:4127,212
0
27,212Form 4
Viehbacher Christopher
President and CEO
2024-02-09 19:56:5727,025
0
27,025Form 4
DORSA CAROLINE
Director
2024-06-25 17:06:4426,607
0
26,607Form 4
DiPietro Kenneth
EVP Human Resources
2017-03-02 17:12:0325,254
0
25,254Form 4
Karaboutis Adriana
EVP, Tech, Bus. Sol & Corp Aff
2017-03-02 17:16:0624,644
0
24,644Form 4
SCHNEIER CRAIG ERIC
EVP, HR, Public Affairs & Comm
2011-03-03 15:17:0222,701
460
23,161Form 4
WIGGINS MARK C
EVP Corp. and Bus. Dev.
2008-09-29 15:21:3622,780
0
22,780Form 4
MCDONNELL MICHAEL R
EVP, Chief Financial Officer
2024-02-21 21:29:4822,090
0
22,090Form 4
Rowinsky Eric K
Director
2024-06-25 17:18:0721,969
0
21,969Form 4
ADELMAN BURT A
EVP, Portfolio Strategy
2008-02-14 17:43:5321,737
0
21,737Form 5
PANGIA ROBERT W
Director
2021-02-09 16:14:204,632
16,000
20,632Form 5
SHERWIN STEPHEN A
Director
2024-06-25 17:20:4920,078
0
20,078Form 4
KELLOGG PETER N
EVP, Finance and CFO
2007-03-22 09:38:3218,966
0
18,966Form 4
LYTTON MICHAEL
EVP Corporate & Business Devel
2010-03-04 13:27:5718,869
0
18,869Form 4
YOUNG WILLIAM
Director
2014-01-09 16:24:3718,509
0
18,509Form 4
Karp Daniel
EVP, Corporate Development
2020-02-14 18:36:1916,434
0
16,434Form 4
Holtzman Steven H
EVP Corporate Development
2016-02-25 16:59:2816,399
0
16,399Form 4
Gregory Ginger
EVP, Human Resources
2024-02-21 21:36:1015,463
0
15,463Form 4
Mulligan Richard
Director
2022-06-17 17:03:5415,099
0
15,099Form 4
Granata Francesco
EVP Global Commercial Operatio
2012-02-03 14:53:2613,925
0
13,925Form 4
LEAMING NANCY
Director
2021-07-02 17:29:4613,763
0
13,763Form 4
Pawlicki Raymond
SVP, Chief Information Officer
2013-11-25 14:11:0213,190
0
13,190Form 4
DEKKERS MARIJN E
Director
2009-06-05 11:06:1312,570
0
12,570Form 4
SCHENK LYNN
Director
2019-06-20 17:59:169,032
3,100
12,132Form 4
WILLIAMS DOUGLAS E
EVP Research & Development
2015-06-22 16:15:0211,817
0
11,817Form 4
BEST LAWRENCE C
Director
2008-06-23 16:08:1811,300
0
11,300Form 4
GLASSBERG ALAN
Director
2008-06-23 16:10:2011,300
0
11,300Form 4
Clancy Paul J
Executive VP and CFO
2017-04-27 16:23:5210,813
0
10,813Form 4
MacLean Michael F
SVP, Chief Accounting Officer
2010-10-04 16:14:3510,681
0
10,681Form 4
Izzar Rachid
Head of Global Product Strat.
2024-02-21 21:33:4810,508
0
10,508Form 4
Sandrock Alfred
Head of Research & Development
2021-06-09 19:05:5710,169
0
10,169Form 4
ROSS BRUCE
Director
2010-06-10 17:06:009,900
0
9,900Form 4
Murphy Nicole
Head of Pharm Ops and Tech
2024-04-03 20:11:149,634
0
9,634Form 4
Ehlers Michael D
EVP, Research and Development
2019-06-04 16:56:289,401
0
9,401Form 4
Posner Brian S
Director
2023-01-27 18:31:548,025
0
8,025Form 5
McKenzie Paul
EVP Pharmaceutical Oper & Tech
2019-03-05 16:17:147,515
0
7,515Form 4
Mantas Jesus B
Director
2024-06-25 17:19:337,388
0
7,388Form 4
Singhal Priya
Head of Development
2024-09-05 06:00:086,985
0
6,985Form 4
Kramer Robin
Chief Accounting Officer
2024-02-21 21:31:366,764
0
6,764Form 4
HAWKINS WILLIAM A
Director
2024-06-25 17:14:226,490
0
6,490Form 4
Kingsley Stuart A
EVP, Global Comm. Operations
2015-02-25 18:19:266,220
0
6,220Form 4
Galdes Alphonse
EVP Pharmaceutical Oper & Tech
2022-01-21 16:50:345,064
969.37
6,033Form 4
Kress Jean-Paul
EVP Pres Int'l & Global Hd GTO
2017-07-05 19:18:434,660
0
4,660Form 4
Freire Maria C
Director
2024-06-25 17:13:064,445
0
4,445Form 4
Gagnon Robert E.
Vice President, Finance
2012-03-01 15:23:233,999
0
3,999Form 4
Artavanis-Tsakonas Spyridon
EVP, Chief Scientific Officer
2016-04-05 17:06:193,150
0
3,150Form 4
LANGER SUSAN
Director
2024-06-25 17:16:402,759
0
2,759Form 4
Keeney Adam
Head of Corporate Development
2024-05-03 20:00:372,539
0
2,539Form 4
Koppel Adam
EVP, Strategy and Bus. Dev.
2016-06-07 16:09:072,402
0
2,402Form 4
JONES WILLIAM D
Director
2022-06-17 17:00:462,145
0
2,145Form 4
Grogan Jane
Head of Research
2024-11-04 16:39:181,881
0
1,881Form 4
Patolawala Monish D
Director
2024-06-25 17:15:361,340
0
1,340Form 4
GOOD MARY L
Director
2007-05-30 17:24:401,250
0
1,250Form 4
KELLER THOMAS F
Director
2008-03-07 17:02:550
1,250
1,250Form 4/A
COVINO GREGORY F
VP, Chief Accounting Officer
2018-03-05 16:35:11531
0
531Form 4
Minor Lloyd
Director
2024-10-07 19:08:270
0
0Form 3